These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25264075)

  • 61. Use of a Molecular Switch Probe to Activate or Inhibit GIRK1 Heteromers In Silico Reveals a Novel Gating Mechanism.
    Gazgalis D; Cantwell L; Xu Y; Thakur GA; Cui M; Guarnieri F; Logothetis DE
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142730
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery, synthesis and biological characterization of a series of
    Sharma S; Lesiak L; Aretz CD; Du Y; Kumar S; Gautam N; Alnouti Y; Dhuria NV; Chhonker YS; Weaver CD; Hopkins CR
    RSC Med Chem; 2021 Aug; 12(8):1366-1373. PubMed ID: 34458739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advances in Targeting GIRK Channels in Disease.
    Zhao Y; Gameiro-Ros I; Glaaser IW; Slesinger PA
    Trends Pharmacol Sci; 2021 Mar; 42(3):203-215. PubMed ID: 33468322
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents.
    Xu Y; Cantwell L; Molosh AI; Plant LD; Gazgalis D; Fitz SD; Dustrude ET; Yang Y; Kawano T; Garai S; Noujaim SF; Shekhar A; Logothetis DE; Thakur GA
    J Biol Chem; 2020 Mar; 295(11):3614-3634. PubMed ID: 31953327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain Models.
    Abney KK; Bubser M; Du Y; Kozek KA; Bridges TM; Linsdley CW; Daniels JS; Morrison RD; Wickman K; Hopkins CR; Jones CK; Weaver CD
    ACS Chem Neurosci; 2019 Mar; 10(3):1294-1299. PubMed ID: 30474955
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.
    Wieting JM; Vadukoot AK; Sharma S; Abney KK; Bridges TM; Daniels JS; Morrison RD; Wickman K; Weaver CD; Hopkins CR
    ACS Chem Neurosci; 2017 Sep; 8(9):1873-1879. PubMed ID: 28697302
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optical control of neuronal activity using a light-operated GIRK channel opener (LOGO).
    Barber DM; Schönberger M; Burgstaller J; Levitz J; Weaver CD; Isacoff EY; Baier H; Trauner D
    Chem Sci; 2016; 7(3):2347-2352. PubMed ID: 28090283
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors.
    Wen W; Wu W; Romaine IM; Kaufmann K; Du Y; Sulikowski GA; Weaver CD; Lindsley CW
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4562-6. PubMed ID: 23838260
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.
    Ramos-Hunter SJ; Engers DW; Kaufmann K; Du Y; Lindsley CW; Weaver CD; Sulikowski GA
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5195-8. PubMed ID: 23916258
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels.
    Kozek KA; Du Y; Sharma S; Prael FJ; Spitznagel BD; Kharade SV; Denton JS; Hopkins CR; Weaver CD
    ACS Chem Neurosci; 2019 Jan; 10(1):358-370. PubMed ID: 30136838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.
    Sharma S; Kozek KA; Abney KK; Kumar S; Gautam N; Alnouti Y; David Weaver C; Hopkins CR
    Bioorg Med Chem Lett; 2019 Mar; 29(6):791-796. PubMed ID: 30718161
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of potent and selective GIRK1/2 modulators via 'molecular switches' within a series of 1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)ureas.
    Wen W; Wu W; Weaver CD; Lindsley CW
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5102-6. PubMed ID: 25264075
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.